Efficacy of Antimalarial Treatments in Colombia
Author Information
Author(s): Blair Silvia, Carmona-Fonseca Jaime, Piñeros Juan G, Ríos Alexandra, Álvarez Tania, Álvarez Gonzalo, Tobón Alberto
Primary Institution: Grupo Malaria, Universidad de Antioquia
Hypothesis
What is the frequency of treatment failure for various antimalarial drugs in patients with non-complicated malaria caused by Plasmodium falciparum in Colombia?
Conclusion
The study highlights the high failure rates of chloroquine and amodiaquine, suggesting a need for improved monitoring and alternative treatments.
Supporting Evidence
- Chloroquine showed an 82% treatment failure rate.
- Amodiaquine had a 30% failure rate.
- Mefloquine had a 4% failure rate.
- Sulphadoxine-pyrimethamine had a 24% failure rate.
- Combination treatments showed lower failure rates, with CQ-SP at 17% and AQ-SP at 2%.
- Active search for patients reduced follow-up loss from over 40% to 6%.
- Early treatment failure was a significant contributor to overall treatment failure.
Takeaway
This study looked at how well different malaria treatments work in Colombia, finding that some don't work very well anymore.
Methodology
The study used a balanced experimental design with eight treatment groups and followed patients for 21 to 28 days to evaluate treatment responses.
Potential Biases
Potential bias due to non-blinded evaluation and loss of patients during follow-up.
Limitations
High initial loss to follow-up, although reduced to 6% through active search and financial support.
Participant Demographics
61% lived in rural areas, 69% were men, and 29% were under 15 years of age.
Statistical Information
P-Value
p<0.05
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website